Peptide record

TPDB44510

Antiviral standard
14 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB44510
Antiviral
Anti-infective peptides
AI4AVP DRAVP 2.0 Peptipedia
standard
No
A 14-aa standard-residue antiviral peptide sequence curated from AI4AVP, DRAVP 2.0, and Peptipedia, with an available 3D structural model.
Sequence
KKKKVVAATYVLVF
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C78H132N18O17
RNDCEQGHIMPSW
KV
1594.02
10.64
4
0
9
+4
-0.20
0.671
125.00
Mammalian: 1.3 hour Yeast: 3 min E.coli: 2 min
1490
0.93
2
Residue Composition
number
2
A
0
R
0
N
0
D
0
C
0
E
0
Q
0
G
0
H
0
I
1
L
4
K
0
M
1
F
0
P
0
S
1
T
0
W
1
Y
4
V
Amino Acid Distribution
A: 2 R: 0 N: 0 D: 0 C: 0 E: 0 Q: 0 G: 0 H: 0 I: 0 L: 1 K: 4 M: 0 F: 1 P: 0 S: 0 T: 1 W: 0 Y: 1 V: 4
Chemical Descriptors
14 reviewed residue count
C78H132N18O17 sequence-only estimate (linear, free termini)
1594.02 sequence-only estimate (linear, free termini)
10.64 sequence-only estimate (linear, free termini)
+4 sequence-only estimate (linear, free termini)
-0.20 sequence-only estimate (linear, free termini)
0.671 sequence-only estimate (linear, free termini)
Evidence Records 1 records
Evidence 1 Activity

Source & Reference

DRAVP 2.0